Literature DB >> 3703160

Increased tumor cell multiplication after radiofrequency lesions in median hypothalamus in the mouse and rat.

M Bindoni, N Belluardo, A E Marchese, V Cardile, G Mudò, S Cella, A Laguidara, G Denatale.   

Abstract

A significant increase of cell multiplication in inoculated ascitic and solid tumors was demonstrated in both DBA/2 and C57BL/6 mice as well as in Wistar rats after radiofrequency lesions in the median hypothalamus (ventromedial and dorsomedial nuclei; part of arcuate nucleus). The following tests were performed: mitotic and metaphasic index, doubling time of tumor, incorporation of tritiated thymidine into DNA, cell cycle parameters and growth fraction. The increased rate of cell proliferation measured was predominantly due to the higher speed of DNA biosynthesis with a minor contribution by an increase of the growth fraction. In the animals with hypothalamic lesions we demonstrated a slight decrease in the secretory activity of the adenohypophysis. Because it is generally stated that failure of hypophysis function hinders cell multiplication in normal and neoplastic tissues, we think that heightened cell proliferation after hypothalamic lesions is due to suppression of an inhibitory mechanism located in the hypothalamus and which is independent of the hypophysis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3703160     DOI: 10.1159/000124479

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  3 in total

1.  Hypothalamic control of certain aspects of natural immunity in the mouse.

Authors:  N Belluardo; G Mudó; S Cella; A Santoni; G Forni; M Bindoni
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

2.  Acute myeloid leukemia in a twin with a suprasellar arachnoid cyst: a possible correlation.

Authors:  S Gangarossa
Journal:  Childs Nerv Syst       Date:  1994-03       Impact factor: 1.475

Review 3.  Neurobiology of cancer: Definition, historical overview, and clinical implications.

Authors:  Boris Mravec
Journal:  Cancer Med       Date:  2021-12-24       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.